-The Hindu For the land-acquirer, the land act ordinance tries to lessen the indirect price of acquisition and transaction by diluting requirements for social impact assessments and referenda. For the land-loser, it not only retains all forms of compensation and rehabilitation, but also grows the number of those eligible for lucrative pay-offs The government of India continues to search for the right way to do land acquisition. Last week, the Union Finance...

-Down to Earth It provides farmers with services to improve productivity and find better prices A non-profit based in Telangana, working on agricultural research and development, has launched a low-cost phone cum tablet computer-phablet-to benefit small holder farmers. "GreenPHABLET will allow information to be precisely targeted to individual smallholder farmers, helping them to purchase inputs at a lower price and get a better price for their produce. It will also link them to...

-The Hindu Business Line Bearish price trends in the global market, poor rainfall took toll on farmers in 2014 Farmers in the country were hit by a double whammy in 2014. Even as poor monsoon affected kharif output, lower commodity prices, largely influenced by a bearish trend in the global market, aggravated the agrarian crisis this year. In addition, the uncertainty over the vagaries of nature, largely through frequent unseasonal rains, compounded...

-The Hindu Business Line   The closure of three urea producing plants in south India has led to a sharp spike in imports and subsidies In April 2014, the UPA government in its last days, cut off the lifeline of three urea plants. It gave a final push to a ten-year-old trend of replacing domestic urea production with imports. The government-owned Madras Fertilisers, and the private sector units SPIC and MCF closed down...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...